- Home
- BCAB vs NUKK Comparison
BCAB vs NUKK Comparison
Compare BCAB & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- NUKK
- Stock Information
- Founded
- BCAB 2007
- NUKK 2013
- Country
- BCAB United States
- NUKK United States
- Employees
- BCAB N/A
- NUKK N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- NUKK Blank Checks
- Sector
- BCAB Health Care
- NUKK Finance
- Exchange
- BCAB Nasdaq
- NUKK Nasdaq
- Market Cap
- BCAB 21.6M
- NUKK 25.4M
- IPO Year
- BCAB 2020
- NUKK N/A
- Fundamental
- Price
- BCAB $0.45
- NUKK $4.33
- Analyst Decision
- BCAB Hold
- NUKK
- Analyst Count
- BCAB 3
- NUKK 0
- Target Price
- BCAB $1.00
- NUKK N/A
- AVG Volume (30 Days)
- BCAB 561.4K
- NUKK 2.8M
- Earning Date
- BCAB 08-07-2025
- NUKK 08-14-2025
- Dividend Yield
- BCAB N/A
- NUKK N/A
- EPS Growth
- BCAB N/A
- NUKK N/A
- EPS
- BCAB N/A
- NUKK N/A
- Revenue
- BCAB $11,000,000.00
- NUKK N/A
- Revenue This Year
- BCAB N/A
- NUKK N/A
- Revenue Next Year
- BCAB N/A
- NUKK N/A
- P/E Ratio
- BCAB N/A
- NUKK N/A
- Revenue Growth
- BCAB N/A
- NUKK N/A
- 52 Week Low
- BCAB $0.24
- NUKK $1.30
- 52 Week High
- BCAB $2.53
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- BCAB 65.33
- NUKK 39.85
- Support Level
- BCAB $0.35
- NUKK $3.31
- Resistance Level
- BCAB $0.38
- NUKK $11.15
- Average True Range (ATR)
- BCAB 0.03
- NUKK 1.03
- MACD
- BCAB 0.01
- NUKK 0.28
- Stochastic Oscillator
- BCAB 90.66
- NUKK 13.01
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).